Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04330664
Title Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California Los Angeles - Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
University of California Irvine Medical Center Orange California 92868 United States Details
Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago Illinois 60611 United States Details
Cancer Center of Kansas - Wichita - Heritage Plaza Wichita Kansas 67214 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Medical Center - Columbus Detroit Michigan 48202 United States Details
Siteman Cancer Center - Washington University Medical Campus Saint Louis Missouri 63130 United States Details
Perlmutter Cancer Center - 34th Street New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center - New York New York New York 10065 United States Details
NEXT Oncology - NEXT San Antonio San Antonio Texas 78229 United States Details
Froedtert Hospital Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field